Brunei Darussalam vs Slovakia: Prevalence rate of hypertension in men aged 30-79
Brunei Darussalam
47
in 2019
Slovakia
47.4
in 2019
Brunei Darussalam rank
27th
Slovakia rank
25th
Prevalence rate of hypertension in men aged 30-79 over time
- Brunei Darussalam
- Slovakia
How they compare
Slovakia currently reports 47.4 against 47 in Brunei Darussalam, a difference of 0.4.
Across all 30 years both countries report, Slovakia has been ahead every year.
Brunei Darussalam ranks 27th and Slovakia ranks 25th of 195 countries.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 39.35 | 46.71 | 7.36 | Slovakia |
| 2000s | 43.45 | 46.8 | 3.35 | Slovakia |
| 2010s | 46.22 | 47.4 | 1.18 | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Brunei Darussalam or Slovakia?
- Slovakia, at 47.4 against 47 in Brunei Darussalam as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Brunei Darussalam and Slovakia?
- 0.4, with Slovakia ahead.
- How many years of comparable data are there for Brunei Darussalam and Slovakia?
- 30 years are reported by both, from 1990 to 2019.
- How do Brunei Darussalam and Slovakia rank globally for prevalence rate of hypertension in men aged 30-79?
- Brunei Darussalam ranks 27th and Slovakia ranks 25th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.